Synergy of Rapamycin and Cyanoacrylate in Reducing Intimal Hyperplasia
AUTOR(ES)
Koike, Marcia Kiyomi
FONTE
Arq. Bras. Cardiol.
DATA DE PUBLICAÇÃO
2019-01
RESUMO
Documentos Relacionados
- The expression and function of G-proteins in experimental intimal hyperplasia.
- Troglitazone inhibits vascular smooth muscle cell growth and intimal hyperplasia.
- Therapeutic approaches to the control of fibrocellular intimal hyperplasia after angioplasty.
- Local gene transfer of tissue factor pathway inhibitor regulates intimal hyperplasia in atherosclerotic arteries
- Basic fibroblast growth factor enhances the coupling of intimal hyperplasia and proliferation of vasa vasorum in injured rat arteries.